One study found that rapamycin prevented radiation-induced secretion of NFκB-driven pro-inflammatory SASP from prostate cancer cells and fibroblasts, thereby inhibiting tumor progression [67]. This evidence concerns the gene NFKB1 and prostate carcinoma.